Low-dose glucocorticoids for long-term control of AAV as effective as…
A combination regimen of low-dose glucocorticoids and rituximab is just as effective in controlling ANCA-associated vasculitis (AAV) as a standard regimen of high-dose glucocorticoids and rituximab, according to data from a clinical trial of two years. Long-term results indicate that although effectiveness is comparable, the risk of serious side effects is significantly reduced with the …